RBC Capital Markets analyst Paul Quinn has boosted his rating on shares of Louisiana-Pacific to 'sector perform' from 'underperform,' citing a positive outlook for the price of oriented strand board because of limited inventory coming to market soon. But Quinn's price target of $15 is still about 8 percent below where LP (Ticker: LPX) ended Monday's session.
Over at Goldman Sachs, analyst Neil Mehta has gone the other way with shares of Delek US Holdings and a number of other oil refiners, cutting them from 'buy' to 'neutral.' Mehta now has a price target of $43 on Delek, which has climbed about 40 percent year to date. His call helped take Delek down almost 5 percent Monday, with shares (Ticker: DK) closing at $37.80.
"While we recognize further upside may exist from restructuring/M&A optionality at DK: (1) risk/reward appears more balanced after share price strength and (2) we expect WTI-Midland differentials will stay compressed with new pipeline capacity additions," the analysts explained.
Delek Logistics Partners will pay almost $62 million to Delek US Holdings, aka The Mothership, for a storage tank at Delek US' refinery in Tyler, Texas, and some unloading racks at its Arkansas plant. The acquisition will add $6.7 million annually to Delek Logistics' EBITDA, which Chairman and CEO Uzi Yemin wants to get to $150 million by year's end. Check out more details here.
Mizuho hospitals analyst Ann Hynes has lowered her rating for shares of LifePoint Hospitals to 'neutral' from 'buy.' Her target for the Brentwood-based company, which opened trading this morning (Ticker: LPNT) at $74.47, is $76.60.
Analysts at Cowen like the prospects of the oil refining group despite the impact of low crude oil prices on other parts of the energy sector. Margins remain strong and summer travel should provide plenty of demand, they say, leading them to lift their estimates on a number of industry players, including Delek US Holdings. They have Brentwood-based Delek (Ticker: DK) climbing to $43 in the coming year from its current levels of about $39.
Avondale Partners analyst Richard Close says investors should jump at the chance to pick up shares of HealthStream after they took an 11 percent lickin' Thursday (Ticker: HSTM) following the company's Q4 report and issuance of 2015 guidance. That guidance of a drop in net income of about a third will scare off some investors, Close said, but it should turn out to be on the conservative side as the company reaps the rewards of various investments. Sticking to his 'market outperform' target and $33 target, Close told clients Thursday that HealthStream "has built an extremely valuable platform and product additions can help sustain steady growth [...] We would get more aggressive on a meaningful pullback."
Over at Deutsche Bank, analysts Ryan Todd and Igor Grinman are nowhere near as bullish on the prospects of Delek US Holdings. They say the Brentwood-based owner of refineries in East Texas and Arkansas is at a relative disadvantage to some competitors and have trimmed their price target to $37 from $40. Delek (Ticker: DK) closed Thursday trading at $32.95.
Hedge fund Lone Pine Capital this week said it has since last August trimmed its stake in Dollar General by almost 5 million shares to 12.9 million, or about 4.3 percent of the Goodlettsville-based retailer. Lone Pine last summer built up its stake in Dollar General as the takeover battle for Family Dollar took shape. Since mid-August, Dollar General (Ticker: DG) is up more than 20 percent.
Making an even more pronounced move out of Delek US Holdings late last year was Steadfast Capital Management, which last spring had doubled its stake in the parent of Mapco to 6.2 percent. The fund run by Robert Pitts Jr. had trimmed its holdings a bit over the summer to 3.1 million shares but got out altogether during the fourth quarter. Stepping in to buy more than 1.3 million of those shares was D.E. Shaw, which now owns 7.2 percent of Delek, up from 5 percent in September.
Delek shares (Ticker: DK) have risen about 5 percent over the past three months.
Bank of America Merrill Lynch analyst Doug Leggate has cut his rating on shares of Delek US Holdings to 'underperform' from 'neutral.' Like so many of its peers, Delek is facing an uncertain couple of quarters ahead as the market adjusts to ever lower crude oil prices. The company's shares (Ticker: DK) are down 16 percent over the past three months but have found firmer footing over the past week and change.
Paul Trussell at Deutsche Bank says Dollar General is one of his best ideas for 2015 even though the company's shares (Ticker: DG) are trading just pennies below their all-time high of $70.50. Trussell has lifted his price target for the discount retail giant to $86 from $73 and says it will benefit from lower gas prices and the growth of its square footage, among others.
At Bank of America Merrill Lynch, analyst Paul Leggate is heading in the opposite direction with his call on Delek US Holdings. On Monday, he cut his rating for the Brentwood-based oil refiner and marketer to 'underperform' from 'neutral' and slashed his price target to $24 from $34. Leggate says Delek, which is changing hands this morning around $26 (Ticker: DK), is facing more competition from other oil infrastructure players and could soon see less crude flowing to its facilities because of the big drop in global oil prices.
POSTDATA: WARRANTY DEEDS